These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9753053)

  • 21. Acute myeloid leukemia with t(6;9) (p23;q34): association with myelodysplasia, basophilia, and initial CD34 negative immunophenotype.
    Alsabeh R; Brynes RK; Slovak ML; Arber DA
    Am J Clin Pathol; 1997 Apr; 107(4):430-7. PubMed ID: 9124211
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Can, a putative oncogene associated with myeloid leukemogenesis, may be activated by fusion of its 3' half to different genes: characterization of the set gene.
    von Lindern M; van Baal S; Wiegant J; Raap A; Hagemeijer A; Grosveld G
    Mol Cell Biol; 1992 Aug; 12(8):3346-55. PubMed ID: 1630450
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Giant cellulitis-like Sweet syndrome as an initial clinical presentation of acute myeloblastic leukemia with t(6;9)(p23;q34): DEK-CAN and internal duplications of FMS-like tyrosine kinase 3.
    Okuyama S; Nito T; Yanagawa N; Tajima K
    Ann Hematol; 2019 Mar; 98(3):787-788. PubMed ID: 30659317
    [No Abstract]   [Full Text] [Related]  

  • 24. KBM-7, a human myeloid leukemia cell line with double Philadelphia chromosomes lacking normal c-ABL and BCR transcripts.
    Andersson BS; Collins VP; Kurzrock R; Larkin DW; Childs C; Ost A; Cork A; Trujillo JM; Freireich EJ; Siciliano MJ
    Leukemia; 1995 Dec; 9(12):2100-8. PubMed ID: 8609723
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loss of the DEK-CAN fusion transcript in a child with t(6;9) acute myeloid leukemia following chemotherapy and allogeneic bone marrow transplantation.
    Boer J; Mahmoud H; Raimondi S; Grosveld G; Krance R
    Leukemia; 1997 Feb; 11(2):299-300. PubMed ID: 9009096
    [No Abstract]   [Full Text] [Related]  

  • 26. Establishment of a novel human myeloid leukemia cell line, AMU-AML1, carrying t(12;22)(p13;q11) without chimeric MN1-TEL and with high expression of MN1.
    Gotou M; Hanamura I; Nagoshi H; Wakabayashi M; Sakamoto N; Tsunekawa N; Horio T; Goto M; Mizuno S; Takahashi M; Suganuma K; Yamamoto H; Hiramatsu A; Watarai M; Shikami M; Imamura A; Mihara H; Taki T; Miwa H; Taniwaki M; Nitta M
    Genes Chromosomes Cancer; 2012 Jan; 51(1):42-53. PubMed ID: 21965128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Establishment of a myeloid leukaemia cell line (Kasumi-4) with t(9;22;11)(q34;q11;q13), inv(3)(q21q26) and the EVI1 gene activation from a patient with chronic myelogenous leukaemia in blast crisis.
    Asou H; Eguchi M; Suzukawa K; Morishita K; Tanaka K; Date M; Hamamoto K; Kamada N
    Br J Haematol; 1996 Apr; 93(1):68-74. PubMed ID: 8611478
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Acute myeloblastic leukemia without maturation (AML-M1) with basophilic elements and associated with translocation t(6;9)].
    Dimicoli S; Fohlen-Walter A; Mansuy L; Buisine J; Grégoire MJ; Lecompte T; Bordigoni P; Jonveaux P; Lesesve JF
    Ann Biol Clin (Paris); 2003; 61(3):352-7. PubMed ID: 12805015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. t(6;9)(p23;q34) presenting acute myeloid leukemia in a child with an unsuspected 45,X/46,X,derY [?t(Yp;Yq)] chromosomal constitution: yet another Y chromosome overdosage and malignancy association.
    Ogur G; Duru F; Ozyurek E; Fisgin T
    J Pediatr Hematol Oncol; 2012 Aug; 34(6):e237-40. PubMed ID: 22278197
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DEK-CAN molecular monitoring of myeloid malignancies could aid therapeutic stratification.
    Garçon L; Libura M; Delabesse E; Valensi F; Asnafi V; Berger C; Schmitt C; Leblanc T; Buzyn A; Macintyre E
    Leukemia; 2005 Aug; 19(8):1338-44. PubMed ID: 15973457
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The translocation (6;9), associated with a specific subtype of acute myeloid leukemia, results in the fusion of two genes, dek and can, and the expression of a chimeric, leukemia-specific dek-can mRNA.
    von Lindern M; Fornerod M; van Baal S; Jaegle M; de Wit T; Buijs A; Grosveld G
    Mol Cell Biol; 1992 Apr; 12(4):1687-97. PubMed ID: 1549122
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The kinetics of relapse in DEK-NUP214-positive acute myeloid leukemia patients.
    Ommen HB; Touzart A; MacIntyre E; Kern W; Haferlach T; Haferlach C; Tobal K; Hokland P; Schnittger S
    Eur J Haematol; 2015 Nov; 95(5):436-41. PubMed ID: 25605311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantification of DEK-CAN fusion transcript by real-time reverse transcription polymerase reaction in patients with t(6;9) acute myeloid leukemia.
    Tobal K; Frost L; Liu Yin JA
    Haematologica; 2004 Oct; 89(10):1267-9. PubMed ID: 15477217
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel human leukaemic cell line, CTS, has a t(6;11) chromosomal translocation and characteristics of pluripotent stem cells.
    Kakuda H; Sato T; Hayashi Y; Enomoto Y; Takayama J; Ohira M; Seto M; Ueda R; Fuse A; Niimi H
    Br J Haematol; 1996 Nov; 95(2):306-18. PubMed ID: 8904886
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute myelomonocytic leukemia (AML-M4) and translocation t(6;9)(p23);q34): two additional patients with prominent myelodysplasia.
    Horsman DE; Kalousek DK
    Am J Hematol; 1987 Sep; 26(1):77-82. PubMed ID: 3477096
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of the translocation breakpoint sequences of two DEK-CAN fusion genes present in t(6;9) acute myeloid leukemia and a SET-CAN fusion gene found in a case of acute undifferentiated leukemia.
    von Lindern M; Breems D; van Baal S; Adriaansen H; Grosveld G
    Genes Chromosomes Cancer; 1992 Oct; 5(3):227-34. PubMed ID: 1384675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical and laboratory study of a complex translocation t (6; 21; 8) (p22; q22; q22) in two patients with acute myeloid leukemia].
    Gong JY; Liu XP; Li CW; Zhao XC; Dai Y; Qin S; Xiao JG; Huang Q; Xu FY; Wang F; Cui W; Liu SH; Wang JX
    Zhonghua Xue Ye Xue Za Zhi; 2006 May; 27(5):314-7. PubMed ID: 16875580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Progenitor cell involvement is predictive of response to induction chemotherapy in paediatric acute myeloid leukaemia.
    Johnston DL; Meshinchi S; Opheim KE; Pallavicini MG; Feusner J; Woods WG; Lange BJ; Radich JP; Bernstein ID
    Br J Haematol; 2003 Nov; 123(3):431-5. PubMed ID: 14617001
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute myeloid leukemia with t(6;9)(p23;q34) is associated with dysplasia and a high frequency of flt3 gene mutations.
    Oyarzo MP; Lin P; Glassman A; Bueso-Ramos CE; Luthra R; Medeiros LJ
    Am J Clin Pathol; 2004 Sep; 122(3):348-58. PubMed ID: 15362364
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aberrant expression of HOXA9, DEK, CBL and CSF1R in acute myeloid leukemia.
    Casas S; Nagy B; Elonen E; Aventín A; Larramendy ML; Sierra J; Ruutu T; Knuutila S
    Leuk Lymphoma; 2003 Nov; 44(11):1935-41. PubMed ID: 14738146
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.